Russell Investments Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-55,871
| Closed | -$4.75M | – | 3296 |
|
|
2020
Q3 | $4.75M | Sell |
55,871
-76,041
| -58% | -$3.85M | 0.01% | 1161 |
|
|
2020
Q2 | $4.67M | Buy |
131,912
+17,854
| +16% | +$522K | 0.01% | 1139 |
|
|
2020
Q1 | $1.54M | Sell |
114,058
-9,258
| -8% | -$156K | ﹤0.01% | 1610 |
|
|
2019
Q4 | $2.61M | Buy |
123,316
+38,157
| +45% | +$673K | ﹤0.01% | 1579 |
|
|
2019
Q3 | $1.13M | Buy |
+85,159
| New | +$1.25M | ﹤0.01% | 1949 |
|
|
2019
Q1 | – | Sell |
-77,502
| Closed | -$1.11M | – | 3070 |
|
|
2018
Q4 | $1.11M | Sell |
77,502
-11,967
| -13% | -$238K | ﹤0.01% | 1894 |
|
|
2018
Q3 | $1.86M | Buy |
89,469
+687
| +0.8% | +$16.3K | ﹤0.01% | 1798 |
|
|
2018
Q2 | $2.1M | Sell |
88,782
-4,306
| -5% | -$86.5K | ﹤0.01% | 1736 |
|
|
2018
Q1 | $1.36M | Sell |
93,088
-24,524
| -21% | -$401K | ﹤0.01% | 2052 |
|
|
2017
Q4 | $1.92M | Buy |
+117,612
| New | +$1.39M | ﹤0.01% | 1842 |
|
|
2017
Q3 | – | Sell |
-57,308
| Closed | -$506K | – | 3041 |
|
|
2017
Q2 | $506K | Sell |
57,308
-1,898
| -3% | -$13.3K | ﹤0.01% | 2402 |
|
|
2017
Q1 | $383K | Buy |
+59,206
| New | +$300K | ﹤0.01% | 2522 |
|
Russell Investments Group's IMMU Position: Q4 2020 in Review
Russell Investments Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 55,871 shares — an estimated $4.75M sold.
Russell Investments Group first reported a position in IMMU in Q1 2017 and held it in 12 quarters. The position peaked at $4.75M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Russell Investments Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Russell Investments Group sold 55,871 Immunomedics Inc shares in Q4 2020, an estimated $4.75M.
- Russell Investments Group first reported a position in Immunomedics Inc in Q1 2017 and held it in 12 quarters.
- Russell Investments Group's Immunomedics Inc position peaked at $4.75M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.